Target intelligence / Profile preview

Microbial metabolic enzyme

Molecular classification
Enzyme, Oxidoreductase, Transferase, Hydrolase, Lyase, Isomerase, Ligase, Translocase
01

Overview

Microbial metabolic enzymes are a broad group of proteins found in bacteria, archaea, and other microbes that catalyze the chemical transformations necessary for microbial life, including energy production, biosynthesis, and cellular maintenance[2][8]. These enzymes span the standard enzyme classes (oxidoreductases, transferases, hydrolase, lyase, isomerase, ligase, and translocase)[1][4][7][10], and are distinguished by their diversity and adaptation to the metabolic needs of specific microbes. Many are considered excellent antimicrobial drug targets due to their essentiality for pathogen survival and differences from host (human) metabolic enzymes; however, successful targeting typically relies on focusing on specific, essential microbial enzymes rather than the broad collective category[3][9]. The selection and characterization of metabolic enzyme drug targets increasingly use metabolic modeling, comparative genomics, and metabolomics to identify unique and essential pathways in pathogens[3][6][9]. Note: For structured annotation, individual enzymes should be specified (e.g., "pyridoxal kinase (PDXK)", "serine hydroxymethyltransferase") rather than the generic "microbial metabolic enzyme."

Other names
microbial enzymebacterial metabolic enzymemicrobial metabolic catalystprokaryotic metabolic enzyme
02

Mechanism of action

Enzyme inhibition (blocking metabolic pathway, impeding pathogen growth); Synthetic lethality (simultaneous inhibition of multiple essential enzymes/metabolites)

03

Biological functions

Energy generationCatabolism of carbohydrates, lipids, proteinsAnabolism (biosynthesis) of cellular constituentsMaintenance of cellular redox balanceMetabolite interconversion
04

Disease associations

InfectionAntibiotic resistancePathogen survival/virulence
05

Safety considerations

Potential off-target effects on human homologous enzymesDisruption of beneficial microbiotaRapid emergence of resistance via pathway redundancy or mutation
06

Interacting drugs

Antibiotics targeting specific metabolic enzymes (e.g. isoniazid, fosfomycin, trimethoprim, sulfonamides, daptomycin)

1 more in the full profile.

07

Biomarkers

Essential metabolites unique to microbes (potentially substrate/product levels of the targeted metabolic enzyme)Pathogen-specific metabolic pathway markers (identified via metabolomics)

Beyond the preview

Go deeper on Microbial metabolic enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial metabolic enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call